Cintas
CTAS · NASDAQ
About CTAS
- Employees
- 48,300
- Headquarters
- Cincinnati, Ohio
- Listed
- Jan 1, 1983
- Sector
- Industrials
- Industry
- Commercial Services & Supplies
- Website
- cintas.com
CTAS key statistics
- Market cap
- 86.18B
- Price-earnings ratio
- 41.87
- Dividend yield
- 0.84%
- Average volume
- 1.88M
- Volume
- 1.31M
- Open price
- $214.28
- High today
- $217.09
- Low today
- $213.21
- 52 Week high
- $219.17
- 52 Week low
- $161.16
Cintas (CTAS) at a glance
Cintas (CTAS) last traded at $217.03, with a market cap of 86.18B, a price-to-earnings ratio of 41.87 and a dividend yield of 0.84%.
Today the stock has traded between $213.21 and $217.09. The current price is 1.8% above the day's low and 0.0% below its high.
Volume so far is 1.31M shares, below the average of 1.88M shares a day.
Over the past year Cintas has ranged from $161.16 to $219.17, and now sits 96% of the way up that range.
Cintas met or beat analyst EPS estimates in 4 of the last 8 quarters. In Q1 FY27 it reported $1.39 per share against an estimate of $1.38.
The average analyst price target is $222.18, 2.4% above the current price, from 11 recent ratings.
Analyst ratings
Latest rating from each analyst over the past 12 months
- Buy54.5%
- Hold36.4%
- Sell9.1%
- Low
- $182.81
- Now
- $217.03
- High
- $262.50
CTAS earnings
Earnings per share, reported against the analyst estimate
Beat the estimate in 4 of the last 8 quarters, by 3.4% on average.
- Q2 FY25: reported $1.09 per share against an estimate of $1.03
- Q3 FY25: reported $1.13 per share against an estimate of $1.08
- Q4 FY25: reported $1.09 per share against an estimate of $1.09
- Q1 FY26: reported $1.20 per share against an estimate of $1.21
- Q2 FY26: reported $1.21 per share against an estimate of $1.22
- Q3 FY26: reported $1.24 per share against an estimate of $1.26
- Q4 FY26: reported $1.30 per share against an estimate of $1.26
- Q1 FY27: reported $1.39 per share against an estimate of $1.38
CTAS news
- Piero Cingari
- Piero Cingari
This Water Stock Is Ready to Become an AI Leader, Bank of America Says
- Lekha Gupta
Cintas Says Volume, Not Price Hikes, Is Powering Its Growth
- Avi Kapoor
Crude Oil Gains 1%; Cintas Earnings Top Views
- Rishabh Mishra
Stock Market Today: Dow, Nasdaq, S&P 500 Futures Drop as Trump Threatens to 'Annihilate' Iran at UNGA—KB Home, Worthington, IONQ in Focus (UPDATED)
- Press releaseBusiness Wire
Cintas Corporation Announces Fiscal 2027 First Quarter Results
- Rishabh Mishra
Stock Market: Will S&P 500 Open Up or Down Today?
- Press releaseBusiness Wire
Cintas Corporation Announces Webcast for First Quarter Fiscal Year 2027 Results
Similar companies
Companies in the same industry as Cintas
Most active stocks
Highest trading volume today
- EARIEntertainment Arts Research$0.0003−16.67%
- SEIISharing Economy International$0.0004+100.00%
- NWGLCL Workshop Group$0.1522+27.90%
- TMSHTrans Global Assets$0.0002+0.00%
- AEFIAmerican EcoFuels$0.0007+0.00%
- CBDW1606$0.0002+0.00%
- FITYFifty 1 Labs$0.0001−66.67%
- PRSOPeraso$0.5914+54.13%
- SDSTStardust Power$0.02−23.66%
- SHFSSHF Holdings$0.0899−4.36%
- FRTTFort Technology$0.7121+32.63%
- CBDLCBD Life Sciences$0.0002−25.00%
Newly listed
Companies that went public in the past six weeks
- TCXBTCGX Acquisition Corp. II$10.56+1.54%
- CTYCITY THERAPEUTICS$20.83−2.94%
- IAMIambic Therapeutics$16.01−2.02%
- AMROAmaero$5.68+1.25%
- FLSCFrazier Life Sciences Acquisition Corp. II$10.28−0.10%
- TRXBTRex Bio$14.44−2.43%
- RTSNRetension Pharmaceuticals$16.18−0.92%
- PAXGUPine Tree Acquisition$9.98+0.00%
- PORTUSouthport Acquisition Corp. IIListed Oct 1, 2026
- CHWMChilwa Minerals$5.18+3.39%
- ACCVAccelevation Holdings$12.31−1.44%
- RZAIROZE AI$10.28+1.28%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.